Omitting surgery could be an option in selected cases when expected benefits are not clear and especially if safer alternative options are available, such as the use of primary endocrine therapy for older patients with early‐stage ER‐positive, HER2‐negative breast cancer59, 60 or radiation therapy for prostate cancer.61 The gene discussed is ERBB2; the disease is prostate cancer.